{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-243671","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.917438+00:00","generated_at":"2026-06-10T08:12:06.956880+00:00","sec_items":["1.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Frequency Therapeutics terminates ATM equity agreement, transfers Nasdaq listing to Capital Market","bullets":["Terminated Equity Distribution Agreement with Oppenheimer; only $50,000 in net proceeds raised from 12,767 shares sold.","Nasdaq approved transfer from Global Select Market to Capital Market effective Sept 28, 2023.","Extended bid price compliance period to March 25, 2024; company plans reverse stock split if needed.","Merger with Korro Bio remains pending; S-4 registration statement already filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-243671","json":"https://secwatch.observer/filing/0001193125-23-243671.json","markdown":"https://secwatch.observer/filing/0001193125-23-243671.md","text":"https://secwatch.observer/filing/0001193125-23-243671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312523243671/0001193125-23-243671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312523243671/d506578d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:12:06.956880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69a63432fa8d84144888594e7f28130e3866f224","claim":"Korro Bio, Inc. terminated Sales Agreement with Oppenheimer & Co. Inc. (effective 2023-09-26).","evidence_excerpt":"On September 26, 2023, the Company delivered written notice to Oppenheimer of termination of the Sales Agreement pursuant to Section 11(b) thereof, effective immediately.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703647/000119312523243671/0001193125-23-243671-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Oppenheimer & Co. Inc."},{"label":"Effective","value":"2023-09-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}